Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01570764
What this trial is testing

Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic SclerosisSclerodermaInterstitial Lung Disease+1 more
Assistance Publique - Hôpitaux de Paris 40
Not applicableStudy completedNCT01443598
What this trial is testing

Pulmonary Hypertension in Interstitial Lung Disease

Who this might be right for
Pulmonary Arterial HypertensionDiffuse Interstitial Lung Disease
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 224
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Large-scale testing (Phase 3)Ended earlyNCT01424033
What this trial is testing

A Clinical Trial for CTD-ILD Treatment

Who this might be right for
Interstitial Lung DiseaseConnective Tissue Disease
University of Michigan 5
Not applicableStudy completedNCT01462006
What this trial is testing

Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisDiffuse Parenchymal Lung DiseaseInterstitial Lung Disease
University of Virginia 32
Large-scale testing (Phase 3)Active Not RecruitingNCT05925803
What this trial is testing

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

Who this might be right for
Systemic SclerosisScleroderma
AstraZeneca 314
Not applicableLooking for participantsNCT07301697
What this trial is testing

Safety and Performance Profile of Cryobiopsy in Bronchial Endoscopy

Who this might be right for
Mediastinal LymphadenopathyMediastinal LesionsDiffuse Interstitial Lung Diseases
University Hospital, Strasbourg, France 30
Large-scale testing (Phase 3)WithdrawnNCT03726398
What this trial is testing

CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH

Who this might be right for
Interstitial Lung DiseaseSclerodermaPulmonary Hypertension
Franz Rischard, DO
Large-scale testing (Phase 3)Looking for participantsNCT06328777
What this trial is testing

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Who this might be right for
Systemic SclerosisSclerodermaInterstitial Lung Diseases
Cabaletta Bio 37
Not applicableNot Yet RecruitingNCT07205627
What this trial is testing

Evaluation of the Diaphragmatic Index Before and After a Pulmonary Rehabilitation Program in Patients With Interstitial Lung Diseases and Its Impact on Quality of Life

Who this might be right for
Lung Disease Interstitial Diffuse
Hospital Civil de Guadalajara 20
Not applicableStudy completedNCT04657484
What this trial is testing

Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease

Who this might be right for
Post COVID-19 Diffuse Lung Disease
Post Graduate Institute of Medical Education and Research, Chandigarh 130
Large-scale testing (Phase 3)Study completedNCT01748084
What this trial is testing

Rituximab in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris 22
Early research (Phase 1)Ended earlyNCT04948554
What this trial is testing

MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)

Who this might be right for
Systemic Sclerosis With and Without Interstitial Lung Disease
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 5
Not applicableStudy completedNCT00453713
What this trial is testing

Race, Ethnicity, and Diffuse Parenchymal Lung Disease

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung DiseaseDiffuse Parenchymal Lung Disease
Columbia University 565
Testing effectiveness (Phase 2)Study completedNCT00883129
What this trial is testing

Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)

Who this might be right for
SclerodermaInterstitial Lung Disease
Michael Roth 142
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Looking for participantsNCT06195072
What this trial is testing

Platform Clinical Study for Conquering Scleroderma

Who this might be right for
Interstitial Lung Disease Due to Systemic DiseaseScleroderma
Scleroderma Research Foundation, Inc. 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT06843239
What this trial is testing

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

Who this might be right for
Systemic Sclerosis (SSc)Scleroderma
Zura Bio Inc 80
Large-scale testing (Phase 3)Active Not RecruitingNCT06025578
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

Who this might be right for
Progressive Pulmonary Fibrosis
Bristol-Myers Squibb 1,057
Not applicableUnknownNCT04392726
What this trial is testing

Ultra-Low Dose Computed Tomography For Diagnosis And Follow-Up Of Patients With Diffuse Parenchymal Lung Disease (DPLD)

Who this might be right for
Diffuse Parenchymal Lung Disease
Sheba Medical Center 30
Next Page